Persistent β2*-Nicotinic Acetylcholinergic Receptor Dysfunction in Major Depressive Disorder
Work
Year: 2012
Type: article
Abstract: Background: Modulation of nicotinic acetylcholine receptors (nAChRs), specifically those containing the β2 subunit, may be effective in treating patients with major depressive disorder. Using [123I]5-... more
Source: American Journal of Psychiatry
Institutions Bristol-Myers Squibb (United States), The University of Texas Southwestern Medical Center, Institute for Neurodegenerative Disorders, Yale University, Bristol-Myers Squibb (Germany)
Cites: 49
Cited by: 108
Related to: 10
FWCI: 4.85
Citation percentile (by year/subfield): 100
Subfield: Molecular Biology
Domain: Life Sciences
Sustainable Development Goal Good health and well-being
Open Access status: green